Correlation Between Salesforce and Astellas Pharma
Can any of the company-specific risk be diversified away by investing in both Salesforce and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Astellas Pharma, you can compare the effects of market volatilities on Salesforce and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Astellas Pharma.
Diversification Opportunities for Salesforce and Astellas Pharma
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Astellas is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Salesforce i.e., Salesforce and Astellas Pharma go up and down completely randomly.
Pair Corralation between Salesforce and Astellas Pharma
Considering the 90-day investment horizon Salesforce is expected to generate 2.01 times more return on investment than Astellas Pharma. However, Salesforce is 2.01 times more volatile than Astellas Pharma. It trades about 0.21 of its potential returns per unit of risk. Astellas Pharma is currently generating about -0.38 per unit of risk. If you would invest 29,889 in Salesforce on August 30, 2024 and sell it today you would earn a total of 3,112 from holding Salesforce or generate 10.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Astellas Pharma
Performance |
| Timeline |
| Salesforce |
| Astellas Pharma |
Salesforce and Astellas Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Astellas Pharma
The main advantage of trading using opposite Salesforce and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Astellas Pharma vs. International Consolidated Airlines | Astellas Pharma vs. Tradeweb Markets | Astellas Pharma vs. National Retail Properties | Astellas Pharma vs. TRADEDOUBLER AB SK |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |